RadNet Net Acquisitions/Divestitures 2010-2024 | RDNT

RadNet net acquisitions/divestitures from 2010 to 2024. Net acquisitions/divestitures can be defined as the total change in cash resulting from both investments in businesses and sales of businesses or business segments.
RadNet Annual Net Acquisitions/Divestitures
(Millions of US $)
2024 $-44
2023 $-11
2022 $-130
2021 $-78
2020 $-31
2019 $-27
2018 $-73
2017 $-19
2016 $-7
2015 $-55
2014 $-9
2013 $-9
2012 $-45
2011 $-43
2010 $-62
2009 $-6
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.521B $1.830B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Quest Diagnostics (DGX) United States $19.694B 19.41
Encompass Health (EHC) United States $12.072B 25.59
DaVita (DVA) United States $10.842B 15.24
Chemed (CHE) United States $8.282B 26.03
Elanco Animal Health (ELAN) United States $6.427B 13.77
Option Care Health (OPCH) United States $5.320B 23.72
Amedisys (AMED) United States $3.076B 20.69
LifeStance Health (LFST) United States $2.252B 0.00
Addus HomeCare (ADUS) United States $2.022B 22.20
Astrana Health (ASTH) United States $1.517B 37.58
U.S Physical Therapy (USPH) United States $1.189B 30.69
Aveanna Healthcare Holdings (AVAH) United States $1.171B 66.67
Pennant (PNTG) United States $1.014B 37.23
Atai Life Sciences (ATAI) Germany $0.327B 0.00
Daxor (DXR) United States $0.036B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.023B 0.00
Ontrak (OTRK) United States $0.007B 0.00
Psychemedics (PMD) United States $0.000B 0.00